1. Home
  2. MBWM vs ABCL Comparison

MBWM vs ABCL Comparison

Compare MBWM & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercantile Bank Corporation

MBWM

Mercantile Bank Corporation

HOLD

Current Price

$50.23

Market Cap

863.0M

Sector

Finance

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$3.44

Market Cap

910.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBWM
ABCL
Founded
1997
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
863.0M
910.0M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
MBWM
ABCL
Price
$50.23
$3.44
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$53.63
$7.75
AVG Volume (30 Days)
77.9K
3.5M
Earning Date
04-21-2026
05-26-2026
Dividend Yield
3.00%
N/A
EPS Growth
10.95
10.91
EPS
5.47
N/A
Revenue
N/A
$75,128,000.00
Revenue This Year
$20.28
N/A
Revenue Next Year
$4.67
$6.30
P/E Ratio
$9.49
N/A
Revenue Growth
N/A
160.56
52 Week Low
$37.76
$1.89
52 Week High
$55.77
$6.52

Technical Indicators

Market Signals
Indicator
MBWM
ABCL
Relative Strength Index (RSI) 38.11 48.73
Support Level $49.95 $3.37
Resistance Level $50.36 $3.57
Average True Range (ATR) 1.73 0.22
MACD -0.42 0.06
Stochastic Oscillator 27.81 54.02

Price Performance

Historical Comparison
MBWM
ABCL

About MBWM Mercantile Bank Corporation

Mercantile Bank Corp operates as a bank holding company. It offers various commercial banking services to individuals, businesses, governmental units, and other institutions. These services include deposit products such as checking, savings, and term certificate accounts and lending products such as commercial, residential mortgage, and installment loans. The company generates revenue from interest and dividends earned on loans, securities, and other financial instruments.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: